Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study

Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.57 -0.05 (8.06%)
Previous Close $0.62    52 Week High $0.00 
Open $0.59    52 Week Low $0.00 
Day High $0.60    P/E N/A 
Day Low $0.56    EPS $0.00 
Volume 535,478       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.57 -0.05 (8.06%)
Previous Close $0.62    52 Week High $0.00 
Open $0.59    52 Week Low $0.00 
Day High $0.60    P/E N/A 
Day Low $0.56    EPS $0.00 
Volume 535,478       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.57 -0.05 (8.06%)
Previous Close $0.62    52 Week High $0.00 
Open $0.59    52 Week Low $0.00 
Day High $0.60    P/E N/A 
Day Low $0.56    EPS $0.00 
Volume 535,478